Skip to main content

Advertisement

SpringerLink
Log in

Letter to Editor: Our concerns about HRT not having a priority as a treatment for osteoporosis in the NOGG guidelines

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL, Harvey N, Kanis J, Leyland S, Low R, McCloskey E, Moss K, Parker J, Paskins Z, Poole K, Reid DM, Stone M, Thomson J, Vine N, Compston J (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58. https://doi.org/10.1007/s11657-022-01061-5

  2. Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH (2017) Menopausal hormone therapy for primary prevention: why the USPSTF is wrong. Climacteric 20(5):402–413. https://doi.org/10.1080/13697137.2017.1362156

    Article  CAS  PubMed  Google Scholar 

  3. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB, Women’s Health Initiative Investigators (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA. 290(13):1729–38. https://doi.org/10.1001/jama.290.13.1729

    Article  CAS  PubMed  Google Scholar 

  4. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI. JAMA. 1996; 276(17):1389–96

  5. Tan DA, Dayu ARB (2022) Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk. Climacteric 25(4):362–368. https://doi.org/10.1080/13697137.2022.2035711

    Article  CAS  PubMed  Google Scholar 

  6. Sackett DL (1997) Evidence-based medicine. Semin Perinatol 21(1):3–5. https://doi.org/10.1016/s0146-0005(97)80013-4

    Article  CAS  PubMed  Google Scholar 

  7. Langer RD (2021) The role of medications in successful aging. Climacteric 24(5):505–512. https://doi.org/10.1080/13697137.2021.1911991

    Article  CAS  PubMed  Google Scholar 

  8. Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL (2020) Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA 324(4):369–380. https://doi.org/10.1001/jama.2020.9482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Simon JA (2012) What’s new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone. Climacteric 15(Suppl 1):3–10. https://doi.org/10.3109/13697137.2012.669332

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Newson Health, Winton House, Church Street, Stratford-Upon-Avon, Warwickshire, CV37 6HB, England

    Louise Newson, Sarah Ball & Rebecca Lewis

Authors
  1. Louise Newson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah Ball
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebecca Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Louise Newson.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Newson, L., Ball, S. & Lewis, R. Letter to Editor: Our concerns about HRT not having a priority as a treatment for osteoporosis in the NOGG guidelines. Osteoporos Int 34, 815–816 (2023). https://doi.org/10.1007/s00198-022-06619-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-022-06619-0

Search

Navigation